CLEC9A and gastric adenocarcinoma: Furthermore, as observed with STAD patients, in the sub-group of LGG with lower sGSN expression, there was a strong correlation between gene signatures for “CLEC9A-ER phagosome pathway” and “effector CD8 T cell-cross-presentation related” (Figure S6L).